Skip Content
You are currently on the new version of our website. Access the old version .

743 Results Found

  • Brief Report
  • Open Access
6 Citations
2,451 Views
9 Pages

Demonstration of Tunable Control over a Delayed-Release Vaccine Using Atomic Layer Deposition

  • Sky W. Brubaker,
  • Isabella R. Walters,
  • Emily M. Hite,
  • Lorena R. Antunez,
  • Emma L. Palm,
  • Hans H. Funke and
  • Bryan L. Steadman

11 July 2024

Many vaccines require multiple doses for full efficacy, posing a barrier for patient adherence and protection. One solution to achieve full vaccination may be attained with single-administration vaccines containing multiple controlled release doses....

  • Article
  • Open Access
6 Citations
3,249 Views
13 Pages

16 February 2023

Coronavirus disease 2019 (COVID-19) vaccines are associated with serious thromboembolic or thrombocytopenic events including vaccine-induced immune thrombocytopenia and thrombosis and immune thrombocytopenia, particularly AZD1222/ChAdOx1. According t...

  • Article
  • Open Access
4 Citations
3,317 Views
26 Pages

8 August 2022

This study investigates the interconnectedness among the stocks of the publicly listed vaccine-producing companies before and after vaccine releases in 2020/21. In doing so, the study utilizes the daily frequency equity returns of the major vaccine p...

  • Communication
  • Open Access
1,268 Views
8 Pages

17 September 2025

Achieving a balance between enhancing both humoral and cellular immunity while ensuring sustained release for attenuated live vaccines has long been a challenge in the vaccine industry. However, the incorporation of chemical materials as nanoadjuvant...

  • Article
  • Open Access
3,729 Views
12 Pages

The Establishment of a Novel γ-Interferon In Vitro Release Assay for the Differentiation of Mycobacterial Bovis-Infected and BCG-Vaccinated Cattle

  • Yuhao Zhao,
  • Wentao Fei,
  • Li Yang,
  • Zhijie Xiang,
  • Xi Chen,
  • Yingyu Chen,
  • Changmin Hu,
  • Jianguo Chen and
  • Aizhen Guo

30 April 2024

BCG vaccination is increasingly reconsidered in the effective prevention of bovine tuberculosis (bTB). However, the primary challenge in BCG vaccination for cattle is the lack of a technique for differentiating between infected and vaccinated animals...

  • Article
  • Open Access
5 Citations
4,883 Views
13 Pages

13 April 2020

Streptococcus parauberis is utilized as an oral vaccine by first inactivating the cells with formalin to produce formalin- killed cells (FKC) and then encapsulating them with polymer beads consisting of a cross-linked alginate-Ca2+ network. The encap...

  • Article
  • Open Access
8 Citations
5,430 Views
13 Pages

Rabies is preventable through vaccination, but the need to mount annual canine vaccination campaigns presents major challenges in rabies control and prevention. The development of a rabies vaccine that ensures lifelong immunity and animal population...

  • Review
  • Open Access
5 Citations
5,948 Views
17 Pages

Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release

  • Franz Schnetzinger,
  • Didier Clénet,
  • Philippe-Alexandre Gilbert,
  • Antonio Guzzi,
  • Marilena Paludi,
  • Jos Weusten and
  • Renske Hesselink

1 September 2024

The rapid development of equitably accessible vaccines is paramount in addressing emerging global health challenges. The safety and efficacy of vaccines hinge significantly on their ability to remain stable from manufacturing throughout the supply ch...

  • Article
  • Open Access
10 Citations
3,811 Views
14 Pages

7 February 2023

Background: Children have an increased risk of developing active tuberculosis (TB) after exposure to Mycobacterium tuberculosis (M.tb), and they are more likely to develop the most severe forms of TB. Rapid diagnosis and treatment of latent M.tb infe...

  • Article
  • Open Access
2 Citations
2,909 Views
18 Pages

An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results

  • Marzena Zalewska,
  • Wiktoria Fus,
  • Adam Konka,
  • Karolina Wystyrk,
  • Aneta Bochenek,
  • Hanna Botor,
  • Martyna Fronczek,
  • Joanna Zembala-John and
  • Brygida Adamek

16 September 2022

This study aimed to assess the magnitude of anti-SARS-CoV-2 immunoglobulin G (IgG) titers and Interferon-Gamma Release Assay (IGRA) test results following administration of booster BNT162b2 in 48 ChAd-primed participants (vaccination schedule: ChAd/C...

  • Article
  • Open Access
6 Citations
3,753 Views
16 Pages

Comparative Study of Optical Markers to Assess Bait System Efficiency Concerning Vaccine Release in the Oral Cavity of Dogs

  • Anna Langguth,
  • Kansuda Leelahapongsathon,
  • Napasaporn Wannapong,
  • Suwicha Kasemsuwan,
  • Steffen Ortmann,
  • Ad Vos and
  • Michael Böer

15 July 2021

Oral vaccination of dogs against rabies has the potential to achieve mass coverage and thus deplete the virus of its most important reservoir host species. There is, however, no established non-invasive method to evaluate vaccine release in the oral...

  • Article
  • Open Access
12 Citations
3,669 Views
16 Pages

Microfluidic Production of Polymeric Core-Shell Microspheres for the Delayed Pulsatile Release of Bovine Serum Albumin as a Model Antigen

  • Renée S. van der Kooij,
  • Rob Steendam,
  • Johan Zuidema,
  • Henderik W. Frijlink and
  • Wouter L. J. Hinrichs

For many vaccines, multiple injections are required to confer protective immunity against targeted pathogens. These injections often consist of a primer administration followed by a booster administration of the vaccine a few weeks or months later. A...

  • Article
  • Open Access
2,992 Views
17 Pages

Recent vaccine scandals have overshadowed China’s accomplishments in public health, triggering discussions on the causes of vaccine incidents. This study aims to review the development of China’s vaccine administration, find out the cause...

  • Article
  • Open Access
3 Citations
3,686 Views
23 Pages

A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice

  • Renée S. van der Kooij,
  • Martin Beukema,
  • Anke L. W. Huckriede,
  • Johan Zuidema,
  • Rob Steendam,
  • Henderik W. Frijlink and
  • Wouter L. J. Hinrichs

Although vaccination is still considered to be the cornerstone of public health care, the increase in vaccination coverage has stagnated for many diseases. Most of these vaccines require two or three doses to be administered across several months or...

  • Article
  • Open Access
1 Citations
1,991 Views
12 Pages

Performance Evaluation of Three Antibody Binding Assays, a Neutralizing Antibody Assay, and an Interferon-Gamma Release Assay for SARS-CoV-2 According to Vaccine Type in Vaccinated Group

  • Minjeong Nam,
  • Jae Hyun Cha,
  • Sang-Wook Kim,
  • Sun Bean Kim,
  • Ki-Byung Lee,
  • You-Seung Chung,
  • Seung Gyu Yun,
  • Myung-Hyun Nam,
  • Chang Kyu Lee and
  • Yunjung Cho

18 December 2023

We evaluated the performance of SARS-CoV-2 assays in the vaccinated group using receptor-binding domain antibody assays (RBD Ab assay), neutralizing antibody assay (nAb assay), and interferon-gamma release assay (IGR assay). We also compared the perf...

  • Article
  • Open Access
6 Citations
4,776 Views
18 Pages

Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines

  • Kerr D. G. Samson,
  • Eleonore C. L. Bolle,
  • Mariah Sarwat,
  • Tim R. Dargaville and
  • Ferry P. W. Melchels

Single-administration vaccine delivery systems are intended to improve the efficiency and efficacy of immunisation programs in both human and veterinary medicine. In this work, an osmotically triggered delayed delivery device was developed that was a...

  • Article
  • Open Access
2 Citations
4,596 Views
18 Pages

Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study

  • Max Beugeling,
  • Katie Amssoms,
  • Freek Cox,
  • Ben De Clerck,
  • Ellen Van Gulck,
  • Jeroen A. Verwoerd,
  • Guenter Kraus,
  • Dirk Roymans,
  • Lieven Baert and
  • Wouter L. J. Hinrichs
  • + 1 author

Currently, there is an increasing interest to apply pre-fusion (pre-F) protein of respiratory syncytial virus (RSV) as antigen for the development of a subunit vaccine. A pre-F-containing powder would increase the flexibility regarding the route of a...

  • Article
  • Open Access
1 Citations
3,564 Views
19 Pages

In Vitro Assessment of a Doubly Adjuvanted Self-Emulsified Nanoemulsion as a Delivery Vehicle for Antigenic Proteins

  • Evgenia Tsanaktsidou,
  • Maritsa Margaroni,
  • Evdokia Karagouni,
  • Costas Kiparissides and
  • Olga Kammona

Background/Objectives: Leishmaniasis is a prevailing infectious disease transmitted via infected phlebotomine sandflies. The lack of an efficient vaccine with respect to immunogenic antigens and adjuvanted delivery systems impedes its control. Follow...

  • Article
  • Open Access
42 Citations
5,408 Views
14 Pages

Recombinant Filamentous Bacteriophages Encapsulated in Biodegradable Polymeric Microparticles for Stimulation of Innate and Adaptive Immune Responses

  • Rezvan Jamaledin,
  • Rossella Sartorius,
  • Concetta Di Natale,
  • Raffaele Vecchione,
  • Piergiuseppe De Berardinis and
  • Paolo Antonio Netti

Escherichia coli filamentous bacteriophages (M13, f1, or fd) have attracted tremendous attention from vaccinologists as a promising immunogenic carrier and vaccine delivery vehicle with vast possible applications in the development of vaccines. The u...

  • Short Note
  • Open Access
3,095 Views
5 Pages

Luteinizing Hormone Releasing Hormone/Galactose Core/Lipopeptide

  • Pavla Simerska,
  • Hoi Ling Lai and
  • Istvan Toth

16 December 2015

A self-adjuvanting vaccine candidate comprising four copies of luteinizing hormone releasing hormone (LHRH), a galactose carrier/core and lipoamino acid based adjuvant was synthesized in 21% yield by a solid phase peptide synthesis, carbohydrate and...

  • Article
  • Open Access
5 Citations
3,306 Views
18 Pages

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers

  • Natalia Syrimi,
  • Flora Sourri,
  • Maria-Christina Giannakopoulou,
  • Dimitrios Karamanis,
  • Asterios Pantousas,
  • Persefoni Georgota,
  • Eleni Rokka,
  • Zoe Vladeni,
  • Euaggelia Tsiantoula and
  • Dimitrios Hatzigeorgiou
  • + 8 authors

28 April 2023

In this study, we aimed to illustrate the trajectory of humoral and cellular immunity nine months after primary vaccination with the BNT162b2 mRNA vaccine among 189 healthcare workers (HCWs). Additionally, we endeavored to identify correlations betwe...

  • Article
  • Open Access
5 Citations
4,937 Views
13 Pages

Evaluation of Quality Control Methods for Foot-And-Mouth Disease Vaccines by High-Performance Liquid Chromatography

  • Mun-Hyeon Kim,
  • Seon-Jong Yun,
  • Yeon-Hee Kim,
  • Hyang-Sim Lee,
  • Ji-Yeon Kim,
  • Ji-Ye Kim,
  • JeongWoo Kang,
  • Yong-Sang Kim and
  • Min-Goo Seo

Foot-and-mouth disease (FMD) is considered one of the highly contagious viral infections affecting livestock. In Korea, an FMD vaccination policy has been implemented nationwide since 2010 for the prevention and control of FMD. Since the vaccines are...

  • Article
  • Open Access
9 Citations
2,559 Views
13 Pages

Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy

  • Christina Woopen,
  • Marie Dunsche,
  • Georges Katoul Al Rahbani,
  • Anja Dillenseger,
  • Yassin Atta,
  • Rocco Haase,
  • Catarina Raposo,
  • Rosetta Pedotti,
  • Tjalf Ziemssen and
  • Katja Akgün

7 September 2023

Our objective was to analyze longitudinal cellular and humoral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in people with multiple sclerosis (pwMS) on B-cell depleting treatment (BCDT) compared to pwMS...

  • Brief Report
  • Open Access
1,547 Views
10 Pages

Humoral and Cell-Mediated Immunity Against SARS-CoV-2 in Healthcare Personnel Who Received Multiple mRNA Vaccines: A 4-Year Observational Study

  • Hideaki Kato,
  • Kaori Sano,
  • Kei Miyakawa,
  • Takayuki Kurosawa,
  • Kazuo Horikawa,
  • Yayoi Kimura,
  • Atsushi Goto and
  • Akihide Ryo

Background/Objectives: The long-term effects of multiple updated vaccinations against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have not been clarified. Humoral or cellular immunity dynamics in healthcare workers for four years wer...

  • Review
  • Open Access
59 Citations
14,022 Views
32 Pages

Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms

  • Maria Chountoulesi,
  • Stergios Pispas,
  • Ioulia K. Tseti and
  • Costas Demetzos

31 March 2022

Lyotropic liquid crystals result from the self-assembly process of amphiphilic molecules, such as lipids, into water, being organized in different mesophases. The non-lamellar formed mesophases, such as bicontinuous cubic (cubosomes) and inverse hexa...

  • Brief Report
  • Open Access
8 Citations
3,158 Views
8 Pages

Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19

  • Jesús San Román,
  • Francisco Javier Candel,
  • Juan Carlos Sanz,
  • Paloma López,
  • Rocío Menéndez-Colino,
  • Pablo Barreiro,
  • María del Mar Carretero,
  • Marta Pérez-Abeledo,
  • José Manuel Viñuela-Prieto and
  • on behalf of the Investigators of the SeroVAC Study
  • + 5 authors

2 March 2022

Background: Most residents and staff in nursing homes have received full vaccination. Factors related to the immune response to vaccination might be related to the risk of future severe COVID-19 and may guide the need for vaccine boosters. Design: Nu...

  • Article
  • Open Access
2,339 Views
14 Pages

25 April 2024

Background: As the SARS-CoV-2 virus remains one of the main causes of severe respiratory system infections, the Food and Drug Administration strongly advises the continuation of current vaccination programs, including the distribution of updated boos...

  • Article
  • Open Access
1,479 Views
21 Pages

A Comparison of Tests for Detecting Prior Exposure to Coxiella burnetii for Use with Q-VAX in Australian Human Q Fever Vaccination

  • Stephen Graves,
  • Jennifer Robson,
  • Anja Scholzen,
  • Richard Dzeng,
  • Francisca Powell-Romero,
  • Jennifer Evans,
  • John Stenos,
  • Meg Jeppesen,
  • Milou L. C. E. Kouwijzer and
  • Ann E. Sluder
  • + 11 authors

Background/Objectives: Q-VAX vaccine, approved in Australia, prevents Q fever. However, individuals with prior Coxiella burnetii (Cb) infection have an increased risk of adverse reactions, requiring pre-vaccination screening by an intradermal hyperse...

  • Review
  • Open Access
26 Citations
3,765 Views
16 Pages

The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic

  • Linda Petrone,
  • Alessandro Sette,
  • Rory D. de Vries and
  • Delia Goletti

Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2 infection and severe COVID-19, although they are not the only contributing factor to immunity: T-cell responses are considered important in protecting against severe...

  • Communication
  • Open Access
20 Citations
5,732 Views
8 Pages

Immune Response to COVID-19 mRNA Vaccine—A Pilot Study

  • Andrzej Lange,
  • Agata Borowik,
  • Jolanta Bocheńska,
  • Joanna Rossowska and
  • Emilia Jaskuła

Twenty individuals (17 females, 3 males, aged 31–65 years (range), median: 46) who received both doses of the BioNTech Pfizer mRNA vaccine were examined (11 to 31 days, median: 25) after the second dose for the presence of antibodies against peptides...

  • Article
  • Open Access
3 Citations
3,185 Views
12 Pages

Cellular Immune Response in Patients Immunized with Three Vaccine Doses of Different Vaccination Schemes Authorized by the Chilean Ministry of Health in January 2022

  • Paz Beatriz Tabilo Valenzuela,
  • Gabriela Flores Balter,
  • Gustavo Saint-Pierre Contreras,
  • Daniel Conei Valencia,
  • Catalina Moreno Calderón,
  • Constanza Bohle Venegas,
  • Marcia Guajardo Rivera,
  • Francisco Silva Ojeda and
  • Maria Jesus Vial Covarrubias

5 April 2022

In December 2019, a case of atypical pneumonia was reported in Wuhan, China. It was named COVID-19 and caused by SARS-CoV-2. In a few months, scientific groups around the world developed vaccines to reduce the disease’s severity. The objective...

  • Article
  • Open Access
3 Citations
2,542 Views
12 Pages

Risk Factors for Impaired Cellular or Humoral Immunity after Three Doses of SARS-CoV-2 Vaccine in Healthy and Immunocompromised Individuals

  • Jae-Hoon Ko,
  • Choon-Mee Kim,
  • Mi-Seon Bang,
  • Da-Yeon Lee,
  • Da-Young Kim,
  • Jun-Won Seo,
  • Na-Ra Yun,
  • Jin-Young Yang,
  • Kyong-Ran Peck and
  • Dong-Min Kim
  • + 7 authors

Background: We aimed to identify the risk factors for impaired cellular and humoral immunity after three doses of the SARS-CoV-2 vaccine. Methods: Six months after the third vaccine dose, T-cell immunity was evaluated using interferon-gamma release a...

  • Review
  • Open Access
19 Citations
6,023 Views
25 Pages

Responsive Microneedles as a New Platform for Precision Immunotherapy

  • Xinyang Liu,
  • Haohao Song,
  • Tairan Sun and
  • Hai Wang

Microneedles are a well-known transdermal or transdermal drug delivery system. Different from intramuscular injection, intravenous injection, etc., the microneedle delivery system provides unique characteristics for immunotherapy administration. Micr...

  • Article
  • Open Access
1 Citations
1,820 Views
10 Pages

The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study

  • Giulia Anna Maria Luigia Costanzo,
  • Giuseppina Sanna,
  • Francesco Pes,
  • Carla Maria Deiana,
  • Andrea Giovanni Ledda,
  • Andrea Perra,
  • Vanessa Palmas,
  • Valeria Manca,
  • Michela Miglianti and
  • Davide Firinu
  • + 4 authors

Immunization against COVID-19 is needed in patients with immune-mediated inflammatory diseases (IMIDs). However, data on long-term immunity kinetics remain scarce. This study aimed to compare the humoral and cellular response to COVID-19 in patients...

  • Review
  • Open Access
46 Citations
8,220 Views
34 Pages

Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective

  • Mubashar Rehman,
  • Nayab Tahir,
  • Muhammad Farhan Sohail,
  • Muhammad Usman Qadri,
  • Sofia O. D. Duarte,
  • Pedro Brandão,
  • Teresa Esteves,
  • Ibrahim Javed and
  • Pedro Fonte

Oils and lipids help make water-insoluble drugs soluble by dispersing them in an aqueous medium with the help of a surfactant and enabling their absorption across the gut barrier. The emergence of microemulsions (thermodynamically stable), nanoemulsi...

  • Article
  • Open Access
1 Citations
1,668 Views
17 Pages

29 November 2024

Background: Cellular and humoral immunity are key to the immune response against SARS-CoV-2, but the comparability and correlation across different assays remain underexplored. This study compares three T-cell and three antibody assays in two vaccine...

  • Feature Paper
  • Article
  • Open Access
45 Citations
15,001 Views
26 Pages

23 April 2021

Supplying SARS-COVID-19 vaccines in quantities to meet global demand has a bottleneck in manufacturing capacity. Assessment of existing mRNA (messenger ribonucleic acid) vaccine processing shows the need for digital twins enabled by process analytica...

  • Article
  • Open Access
1,674 Views
15 Pages

27 November 2024

Despite the growing body of evidence addressing the reasons behind vaccine hesitancy, the positive role of media as a key environmental factor influencing vaccination, as well as its function in publicizing and encouraging vaccination, has been less...

  • Article
  • Open Access
11 Citations
6,474 Views
13 Pages

Transient Biocompatible Polymeric Platforms for Long-Term Controlled Release of Therapeutic Proteins and Vaccines

  • Handan Acar,
  • Saikat Banerjee,
  • Heliang Shi,
  • Reihaneh Jamshidi,
  • Nastaran Hashemi,
  • Michael W. Cho and
  • Reza Montazami

28 April 2016

Polymer-based interpenetrating networks (IPNs) with controllable and programmable degradation and release kinetics enable unique opportunities for physisorption and controlled release of therapeutic proteins or vaccines while their chemical and struc...

  • Article
  • Open Access
12 Citations
4,439 Views
14 Pages

Effects of a Recombinant Gonadotropin-Releasing Hormone Vaccine on Reproductive Function in Adult Male ICR Mice

  • Ai-Mei Chang,
  • Chen-Chih Chen,
  • Ding-Liang Hou,
  • Guan-Ming Ke and
  • Jai-Wei Lee

Gonadotropin-releasing hormone (GnRH) regulates the reproductive endocrine system in mammals. The GnRH immunocontraception vaccine can aid animal population control and management. We evaluated a recombinant GnRH fusion protein with the adjuvant MONT...

  • Review
  • Open Access
79 Citations
21,563 Views
25 Pages

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity

  • Liusheng Wu,
  • Xiaoqiang Li,
  • Xinye Qian,
  • Shuang Wang,
  • Jixian Liu and
  • Jun Yan

12 February 2024

In recent years, lipid nanoparticles (LNPs) have attracted extensive attention in tumor immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great research interest. mRNA vaccines are a potential choice for tumor immunothe...

  • Article
  • Open Access
3 Citations
2,489 Views
15 Pages

Photodynamic therapy (PDT)-based cancer vaccines are shown to be more effective modalities for treating cancer in animal models compared to other methods used to generate cancer cell-derived vaccines. The higher efficacy seems to stem from the genera...

  • Article
  • Open Access
5 Citations
3,996 Views
11 Pages

Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination

  • Katharina Grikscheit,
  • Holger F. Rabenau,
  • Zahra Ghodratian,
  • Marek Widera,
  • Alexander Wilhelm,
  • Tuna Toptan Grabmair,
  • Sebastian Hoehl,
  • Emily Layer,
  • Fabian Helfritz and
  • Sandra Ciesek

21 July 2022

The emergence of SARS-CoV-2 Omicron subvariants prompted countries to call for accelerated booster vaccinations to limit disease and transmission. Here, we characterized correlates of protection over time after the second booster or after Omicron BA....

  • Article
  • Open Access
2 Citations
4,714 Views
11 Pages

BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release

  • Dorcas O. Owusu,
  • Ernest Adankwah,
  • Wilfred Aniagyei,
  • Isaac Acheampong,
  • Difery Minadzi,
  • Augustine Yeboah,
  • Joseph F. Arthur,
  • Millicent Lamptey,
  • Monika M. Vivekanandan and
  • Marc Jacobsen
  • + 9 authors

17 April 2023

Mycobacterium (M.) bovis BCG vaccination is recommended for healthy babies after birth in several countries with a high prevalence of tuberculosis, including Ghana. Previous studies showed that BCG vaccination prevents individuals from developing sev...

  • Article
  • Open Access
1,331 Views
17 Pages

Immunogenicity and Contraceptive Potential of a Classical Swine Fever Viral Vector Live Vaccine Strain Containing Pig Gonadotropin-Releasing Hormone

  • Dong-Jun An,
  • Ji-Hee Shin,
  • SeEun Choe,
  • Young-Hyeon Lee,
  • Min-Kyung Jang,
  • Byung-Hyun An,
  • Gyu-Nam Park,
  • Yun-Sang Cho and
  • Kyung-Soo Chang

12 October 2025

Background: Classical swine fever virus (CSFV) is a highly contagious and fatal disease in pigs and wild boars. While hunting and bait vaccination are effective for CSFV eradication, additional strategies are needed to control wild boar populations....

  • Article
  • Open Access
6 Citations
3,252 Views
14 Pages

19 January 2020

The peptide adjuvant, pleurocidin (PLE), and the Vibrio harveyi antigen, recombinant glyceraldehyde-3-phosphate dehydrogenase (rGAPDH) protein, were encapsulated with poly (lactide-co-glycolide) (PLG) polymers in our previous study to produce PLG-enc...

  • Article
  • Open Access
14 Citations
7,184 Views
18 Pages

Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release

  • Johanna Poecheim,
  • Simon Heuking,
  • Livia Brunner,
  • Christophe Barnier-Quer,
  • Nicolas Collin and
  • Gerrit Borchard

17 December 2015

Adjuvants enhance immunogenicity of vaccines through either targeted antigen delivery or stimulation of immune receptors. Three cationic nanoparticle formulations were evaluated for their potential as carriers for a DNA vaccine, and muramyl dipeptide...

  • Brief Report
  • Open Access
9 Citations
3,375 Views
8 Pages

T-Cell Assay after COVID-19 Vaccination Could Be a Useful Tool? A Pilot Study on Interferon-Gamma Release Assay in Healthcare Workers

  • Silva Seraceni,
  • Elena Zocca,
  • Tamara Emanuela Cervone,
  • Flaminia Tomassetti,
  • Isabella Polidori,
  • Massimiliano Valisi,
  • Francesco Broccolo,
  • Graziella Calugi,
  • Sergio Bernardini and
  • Massimo Pieri

Background: SARS-CoV-2 T-cells are crucial for long-term protection against reinfection. The aim was to demonstrate the Interferon-gamma Release Assay (IGRA) test could be useful for vaccination monitoring. Methods: In a prospective cohort of 98 vacc...

  • Article
  • Open Access
18 Citations
4,709 Views
15 Pages

Sequence Analysis of Egyptian Foot-and-Mouth Disease Virus Field and Vaccine Strains: Intertypic Recombination and Evidence for Accidental Release of Virulent Virus

  • Sahar Abd El Rahman,
  • Bernd Hoffmann,
  • Reham Karam,
  • Mohamed El-Beskawy,
  • Mohammed F. Hamed,
  • Leonie F. Forth,
  • Dirk Höper and
  • Michael Eschbaumer

6 September 2020

In spite of annual mass vaccination programs with polyvalent inactivated vaccines, the incidence and economic impact of foot-and-mouth disease (FMD) in Egypt is high. Viruses of the A, O and SAT 2 serotypes are endemic and repeated incursions of new...

  • Review
  • Open Access
54 Citations
7,275 Views
34 Pages

PLGA Particles in Immunotherapy

  • Dennis Horvath and
  • Michael Basler

Poly(lactic-co-glycolic acid) (PLGA) particles are a widely used and extensively studied drug delivery system. The favorable properties of PLGA such as good bioavailability, controlled release, and an excellent safety profile due to the biodegradable...

of 15